Company Search:
Advanced Search
Sponsored Links
Flexion Therapeutics Inc Company Snapshot
Flexion Therapeutics Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Flexion Therapeutics Inc with three other companies in this sector in UNITED STATES : Theravance Biopharma Inc (2019 sales of $73.41 million of which 100% was Human Therapeutics), Aerie Pharmaceuticals Inc ($69.89 million of which 100% was development and commercialization of pha), and Vivus, Inc. ($69.76 million of which 100% was Development and commercialization of nov).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Flexion Therapeutics Inc
  Stock Performance Chart for Flexion Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 12.34
(Figures in U.S. Dollars)
1 Week -9.1%   13 Weeks 2.9%  
4 Weeks 29.9%   52 Weeks 10.2%  
Flexion Therapeutics Inc Key Data:
  Ticker: FLXN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 72,957,000
(Year Ending Jan 2020).
Employees: 288
  Currency: U.S. Dollars Market Cap: 607,996,637
  Fiscal Yr Ends: December Shares Outstanding: 49,270,392
  Share Type: COMMON Closely Held Shares: 3,075,197
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.